Oral Estradiol Equivalent Dose
The oral estradiol equivalent to a 0.05 mg (50 μg) twice-weekly transdermal patch is 1–2 mg daily. 1
Dosing Conversion
When transdermal estradiol patches are unavailable, the guideline-recommended oral replacement is:
- Oral estradiol: 1–2 mg daily (continuous administration)
- This can be given as monotherapy or combined with a progestogen if the patient has a uterus
The 2021 Blood Reviews guideline explicitly states that patches releasing 50 μg of 17β-estradiol daily (equivalent to your 0.05 mg twice-weekly patch) correspond to oral estradiol tablets containing 1–2 mg daily 1. This conversion is consistently referenced throughout their treatment protocols for hormone replacement therapy.
Important Clinical Considerations
Why Transdermal is Preferred (When Available)
The guidelines strongly favor transdermal over oral estradiol as first-line therapy because:
- Avoids first-pass hepatic metabolism, reducing effects on coagulation factors, SHBG, triglycerides, and inflammatory markers 2
- Lower thromboembolism risk compared to oral formulations 2
- Better metabolic profile for patients with cardiovascular risk factors, hypertension, hypertriglyceridemia, obesity, metabolic syndrome, or diabetes 2
- More stable serum levels with less fluctuation (fluctuation index 0.65 for patches vs 3.68 for oral) 3
Pharmacokinetic Differences
Research demonstrates that oral estradiol produces:
- 12-fold higher average estradiol concentrations than equivalent transdermal doses 3
- Large concentration pulses throughout the day rather than steady levels 3
- 9.4-fold higher estrone levels due to first-pass metabolism 3
Despite these differences, the 1–2 mg oral dose is the established clinical equivalent for symptom control and bone protection.
Progestogen Requirements
If the patient has a uterus, add progestogen for endometrial protection:
- First choice: Micronized progesterone 200 mg daily for 12–14 days every 28 days (sequential regimen) 1
- Alternatives:
- Medroxyprogesterone acetate 10 mg daily for 12–14 days per month
- Dydrogesterone 10 mg daily for 12–14 days per month
- Continuous regimen option: Combined tablets with 1–2 mg estradiol + 5 mg dydrogesterone (or 2 mg dienogest) daily 1
Dose Titration
- Start with 1 mg daily and titrate to 2 mg daily based on symptom response and tolerability 1
- The dose should be adjusted according to the patient's tolerance and sense of wellbeing 1
- Monitor for adequate symptom control while avoiding over-treatment
Common Pitfall
Do not assume dose equivalence based on milligram amounts alone. The 50 μg daily transdermal dose requires a much higher oral dose (1–2 mg = 1000–2000 μg) due to extensive first-pass metabolism and lower bioavailability of oral estradiol.